Proposals On EU-Wide Joint Clinical Assessments Fall Short, Warn German Industry Groups
Executive Summary
The German pharmaceutical industry is calling for “directional correction” to the way implementation of the EU’s Health Technology Assessment Regulation is being developed.
You may also be interested in...
EU Opens Long Awaited Consultation On Joint Clinical Assessments
Stakeholders have until 2 April to comment on the European Commission’s draft implementing act for joint clinical assessments. Industry federation EFPIA says the proposal contains numerous challenges for pharmaceutical sponsors.
European HTA Network Rejects Industry Criticism Of Joint Clinical Assessments
EUnetHTA 21, the EU health technology assessment network that will soon hang up its hat has defended the methodologies it developed to support the EU HTA Regulation in the wake of criticism from industry.
Direction Of Travel Of EU HTA Regulation Is ‘Disappointing’ For Advanced Therapies
Without further work, the EU-wide joint clinical assessments introduced by the EU regulation on health technology assessments will fail to meet the needs of advanced therapies, warns the Alliance for Regenerative Medicine.